Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy

References

• TesfayeSVileikyteLRaymanGToronto Expert Panel on Diabetic NeuropathyPainful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and managementDiabetes Metab Res Rev201127629638
   PubMed Web of Science ®Google Scholar
• JensenTSBackonjaMMHernandezJSTesfayeSValensiPZieglerDNew perspectives on the management of diabetic peripheral neuropathic painDiab Vasc Dis Res2006310811917058631
   PubMedGoogle Scholar
• WongMCChungJWWongTKEffects of treatments for symptoms of painful diabetic neuropathy: systematic reviewBMJ20073358717562735
   PubMed Web of Science ®Google Scholar
• LindsayTJRodgersBCSavathVHettingerKTreating diabetic peripheral neuropathic painAm Fam Physician20108215115820642268
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGHaanpääMEFNS Task ForceEFNS guidelines on pharmacological treatment of neuropathic painEur J Neurol2006131153116917038030
   PubMed Web of Science ®Google Scholar
• BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician200811S105S12018443635
   PubMed Web of Science ®Google Scholar
• Lyrica [package insert]New York, NYPfizer, Inc2012
   Google Scholar
• Cymbalta [package insert]Indianapolis, INEli Lilly and Company2011
   Google Scholar
• QuiliciSChancellorJLöthgrenMMeta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic painBMC Neurol20099619208243
   PubMed Web of Science ®Google Scholar
• KaurHHotaDBhansaliADuttaPBansalDChakrabartiAA comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trialDiabetes Care20113481882221355098
   PubMed Web of Science ®Google Scholar
• BansalDBhansaliAHotaDChakrabartiADuttaPAmitriptyline vs pregabalin in painful diabetic neuropathy: a randomized double blind clinical trialDiabet Med2009261019102619900234
   PubMed Web of Science ®Google Scholar
• BrilVEnglandJFranklinGMAmerican Academy of NeurologyAmerican Association of Neuromuscular and Electrodiagnostic MedicineAmerican Academy of Physical Medicine and RehabilitationEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitationNeurology2011761758176521482920
   PubMed Web of Science ®Google Scholar
• SelvarajahDWilkinsonIDDaviesJGandhiRTesfayeSCentral nervous system involvement in diabetic neuropathyCurr Diab Rep20111131032221667355
   PubMed Web of Science ®Google Scholar
• MarksDMShahMJPatkarAAMasandPSParkGYPaeCUSerotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseCurr Neuropharmacol2009733133620514212
   PubMed Web of Science ®Google Scholar
• DeecherDCBeyerCEJohnstonGDesvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitorJ Pharmacol Exp Ther200631865766516675639
   PubMed Web of Science ®Google Scholar
• BoyerPMontgomerySLepolaUEfficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trialInt Clin Psychopharmacol20082324325318703933
   PubMed Web of Science ®Google Scholar
• LiebowitzMRManleyALPadmanabhanSKGangulyRTummalaRTourianKAEfficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorderCurr Med Res Opin2008241877189018507895
   PubMed Web of Science ®Google Scholar
• DunlopBWReddySYangLLubaczewskiSFochtKGuico-PabiaCJSymptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placeboJ Clin Psychopharmacol20113156957621869698
   PubMed Web of Science ®Google Scholar
• Pristiq [package insert]Philadelphia, PAWyeth Pharmaceuticals, Inc, a subsidiary of Pfizer Inc2013
   Google Scholar
• RowbothamMCGoliVKunzNRLeiDVenlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled studyPain200411069770615288411
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLamoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain20019414915811690728
   PubMed Web of Science ®Google Scholar
• FeldmanELStevensMJClinical testing in diabetic peripheral neuropathyCan J Neurol Sci1994214S3S77874610
   PubMed Web of Science ®Google Scholar
• WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36)Medical Care1992304734831593914
   PubMed Web of Science ®Google Scholar
• LorrMMcNairDMDropplemanLFProfile of mood states technical updateMulti-Health Systems, Inc2005
   Google Scholar
• EuroQol GroupEuroQol – a new facility for the measurement of health-related quality of lifeHealth Policy19901619920810109801
   PubMed Web of Science ®Google Scholar
• ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics1993435336510146874
   PubMed Web of Science ®Google Scholar
• ClaytonAHKornsteinSGRosasGGuico-PabiaCTourianKAAn integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorderCNS Spectr20091418319519407730
   PubMed Web of Science ®Google Scholar
• WernickeJFPritchettYLD’SouzaDNA randomized controlled trial of duloxetine in diabetic peripheral neuropathic painNeurology2006671411142017060567
   PubMed Web of Science ®Google Scholar
• ArmstrongDGChappellASLeTKDuloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomesPain Med2007841041817661854
   PubMed Web of Science ®Google Scholar
• GoldsteinDJLuYDetkeMJLeeTCIyengarSDuloxetine vs placebo in patients with painful diabetic neuropathyPain200511610911815927394
   PubMed Web of Science ®Google Scholar
• TolleTFreynhagenRVersavelMTrostmannUYoungJPJrPregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind studyEur J Pain20081220321317631400
   PubMed Web of Science ®Google Scholar
• GaoYNingGJiaWPDuloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in ChinaChin Med J (Engl)20101233184319221163113
   PubMed Web of Science ®Google Scholar
• MoonDELeeDILeeSCEfficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter studyClin Ther2010322370238521353106
   PubMed Web of Science ®Google Scholar
• GilronIWajsbrotDTherrienFLemayJPregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trialClin J Pain20112718519321178603
   PubMed Web of Science ®Google Scholar
• BoyleJErikssonMEGribbleLRandomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of lifeDiabetes Care2012352451245822991449
   PubMed Web of Science ®Google Scholar
• RaskinJPritchettYLWangFA double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Med2005634635616266355
   PubMed Web of Science ®Google Scholar
• KadirogluAKSitDKayabasiHTuzcuAKTasdemirNYilmazMEThe effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitusJ Diabetes Complications20082224124518413214
   PubMed Web of Science ®Google Scholar
• MaxMBKishore-KumarRSchaferSCEfficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trialPain199145391861872
   PubMed Web of Science ®Google Scholar
• MaxMBLynchSAMuirJShoafSESmollerBDubnerREffects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathyN Engl J Med1992326125012561560801
   PubMed Web of Science ®Google Scholar
• SindrupSHGramLFSkjoldTGrodumEBrosenKBeck-NielsenHClomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over studyBr J Clin Pharmacol1990306836912271367
   PubMed Web of Science ®Google Scholar
• RudrojuNBansalDTalakokkulaSTComparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysisPain Physician201316E705E71424284851
   PubMed Web of Science ®Google Scholar
• KalyaniRRSaudekCDBrancatiFLSelvinEAssociation of diabetes, comorbidities, and A1c with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999–2006Diabetes Care2010331055106020185736
   PubMed Web of Science ®Google Scholar